Navigation Links
NeoStem Appoints Deloitte & Touche as New Independent Registered Public Accounting Firm
Date:3/16/2010

t serviced by a Big Four accounting firm, such as Deloitte & Touche," said Robin Smith, M.D., NeoStem's CEO and Chairman of the board of directors. "We thank HRR for their adept service in recent years and look forward to working with Deloitte & Touche as the Company continues to grow and increase shareholder value."

About NeoStem, Inc.

NeoStem, Inc. is engaged in the development of stem cell-based therapies, pursuit of anti-aging initiatives and building of a network of adult stem cell collection centers in the U.S. and China that are focused on enabling people to donate and store their own (autologous) stem cells for their personal use in times of future medical need. The Company also has licensed various stem cell technologies, including a worldwide exclusive license to VSEL(TM) technology which uses very small embryonic-like stem cells, shown to have several physical characteristics that are generally found in embryonic stem cells, and is pursuing the licensing of other technologies for therapeutic use. NeoStem's majority-controlled Chinese pharmaceutical operation, Suzhou Erye, manufactures and distributes generic antibiotics in China. For more information, please visit: http://www.neostem.com .


'/>"/>
SOURCE NeoStem, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. NeoStem Announces Presentation Time Change at Roth Capital Partners 22nd Annual OC Growth Stock Conference
2. NeoStem Enters into SRA with University of Michigan; Funding from NIH Stem Cell Research Grant
3. NeoStem Prices Public Offering of 5,000,000 Shares of Common Stock
4. Busy Southwestern Orthopedic Practice Joins the NeoStem Stem Cell Collection Network
5. NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company
6. United States Securities and Exchange Commission Declares Effective Registration Statement for NeoStems Acquisition of China Biopharmaceuticals Holdings, Inc. and a Controlling Interest in Leading Chinese Pharmaceutical Company; Meeting of Each Com
7. NeoStem, Inc. Awarded NIH Research and Research Infrastructure Grand Opportunities Grant
8. NeoStem CEO to Participate in 2009 World Stem Cell Summit on September 23rd
9. NeoStem, Inc. is Certified by the State of New York as a Qualified Emerging Technology Company and Notifies Investors of Possible Tax Credit of up to 20%
10. NeoStem, Inc. Appoints Leading Chinese Medical Official to Its Advisory Board
11. NeoStem Featured on CBS2 News; Success of Licensed Stem Cell Treatments Shown for Arthritis and Orthopedic Problems; Procedure to be Used by NeoStem Affiliate in China
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2015)... ... July 31, 2015 , ... R-Biopharm is proud ... partially hydrolyzed gluten in foods, has been accepted by AOAC International as Official ... Gluten in Fermented Cereal-Based Products by R5 Competitive ELISA,” based on a specific ...
(Date:7/30/2015)... 2015   GenoSpace , a leading provider ... analysis of genomic and other biomedical data, today ... the company as Vice President of Sales and ... "GenoSpace partners with its customers ... and explore complex sets of genomic, phenotypic and ...
(Date:7/30/2015)... According to a new market ... PB/PK, PKPD, Trial Design, Toxicity Prediction, In-house, Contract Service), ... by End Users - Global Forecast to 2020", published ... USD 2,107.99 million by 2020 from USD 1,034.93 million ... Browse more than 75 ...
(Date:7/30/2015)... July 30, 2015   Senomyx , Inc. (NASDAQ: ... science technologies to discover, develop, and commercialize novel flavor ... today reported financial results for the second quarter 2015. ... 2015, we remain on track to achieve our commercial ... Executive Officer of the Company. "Since our last quarterly ...
Breaking Biology Technology:RIDASCREEN® Competitve Gliadin Receives AOAC Official First Action Status 2GenoSpace Introduces Matthew Fischer as Vice President of Sales and Marketing 2Biosimulation Market Worth 2,107.99 Million USD by 2020 2Biosimulation Market Worth 2,107.99 Million USD by 2020 3Biosimulation Market Worth 2,107.99 Million USD by 2020 4SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 2SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 3SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 4SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 5SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 6SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 7SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 8SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 9
... , MONROVIA, Calif. and HANGZHOU, China, Nov. ... or the "Company") (OTC Bulletin Board: NIUS), a leading U.S.-based ... children, today announced that the Company,s popular Gummy Bear products ... The Company has entered into a one year distribution contract ...
... CAMBRIDGE, Mass., Nov. 18 Knome, Inc., a ... announced the launch of KnomeDISCOVERY, the first fully ... for researchers. The new offering meets rapidly emerging ... that bundles affordable, research-tailored access to a broad ...
... , BOTHELL, Wash., Nov. 18 ... manufacturer, and marketer of proprietary cGMP hypothermic storage and cryopreservation ... it has been granted a Japanese patent for an application ... death caused by cold temperatures used in biopreservation. The patent ...
Cached Biology Technology:Niusule Expands Geographic Footprint in China 2Niusule Expands Geographic Footprint in China 3Knome Launches First Platform-Agnostic Human Genome Sequencing and Analysis Service for Researchers 2Knome Launches First Platform-Agnostic Human Genome Sequencing and Analysis Service for Researchers 3BioLife Solutions Granted Japanese Biopreservation Patent 2BioLife Solutions Granted Japanese Biopreservation Patent 3
(Date:7/13/2015)... 2015 Synaptics Inc. (NASDAQ: SYNA ... today announced sampling of ClearPad ® 4300, ... (TDDI) product targeting smartphones and tablets. This new ... , best-in-class touch controller IP and systems ... in the company,s Japan Design Center. TDDI enables ...
(Date:7/9/2015)... 2015 Research and ... the "Biometrics for Banking; Market & Technology ... to their offering. The adoption for ... growth and the forecast is that by 2020 ... companies involved in delivering biometric systems to the ...
(Date:7/8/2015)... Summary Pancreatic cancer is the 12th ... with a mortality rate of 10.9 deaths per 100,000 ... patients has highlighted a significant need for new and ... by the current market. A highly active pancreatic ... molecule types and mechanisms of action, which provides a ...
Breaking Biology News(10 mins):Synaptics Announces Sampling of Second Generation TDDI Solutions 2Synaptics Announces Sampling of Second Generation TDDI Solutions 3Global Banking Biometrics Market 2015-2020 - Market & Technology Analysis, Adoption Strategies and Forecasts 2Global Banking Biometrics Market 2015-2020 - Market & Technology Analysis, Adoption Strategies and Forecasts 3Frontier Pharma: Pancreatic Cancer - Identifying and Commercializing First-in-Class Innovation 2Frontier Pharma: Pancreatic Cancer - Identifying and Commercializing First-in-Class Innovation 3
... by the University of Warwick, The Sainsbury Laboratory, and ... sequenced the genome of a plant disease causing organism ... plant pathogens". The research has uncovered the tactics used ... discovery also provides tools for researchers to identify the ...
... 30-year warming trend, the last three years in the Bering ... Alaska Fairbanks scientist says that the cold temperatures have helped ... the way Walleye pollock feed. Alexei Pinchuk, research professional ... three years gathering zooplankton samples in the Bering Sea. He ...
... make teeth stronger and aid in the treatment of osteoporosis. ... killer a carcinogen that causes bone, lung and bladder ... American communities, drinking water and an ingredient in the vast ... of fluoride, be it in water, consumer products or the ...
Cached Biology News:Plant disease 'stealth bomber' tactics subverted to tackle hundreds of plant pathogens 2Plant disease 'stealth bomber' tactics subverted to tackle hundreds of plant pathogens 3Researcher develops accurate method for detecting dangerous fluoride 2Researcher develops accurate method for detecting dangerous fluoride 3Researcher develops accurate method for detecting dangerous fluoride 4
NNT-1/BSF-3 (N-14)...
BI-1 Polyclonal Antibody Storage Temperature: -20C Shipping: gel pack Shelf-Life: 12 months...
... cells of embryonal carcinoma of testis and ovary ... like seminoma. Glandular epithelium of yolk sac tumor ... cells of stomach and acini cells of pancreas ... Epitope: Carbohydrate portion on human embryonal carcinoma ...
... Endogenous potent vasoconstrictor peptide. Displays ... modulates vascular tonus. ET-1, ET-2, and ET-3 ... genes. ET-2 and ET-3 are similar to ... amino acids, respectively. All three isopeptides produce ...
Biology Products: